Zobrazeno 1 - 10
of 16
pro vyhledávání: '"A D Gvozdeva"'
Publikováno v:
Гинекология, Vol 19, Iss 6, Pp 43-45 (2017)
The aim of the study was to assess the effectiveness of auxiliary reproductive technologies (ART) programs in patients with a habitual miscarriage (HM) in an anamnesis. Materials and methods. A prospective cohort study included 200 patients with infe
Externí odkaz:
https://doaj.org/article/5664f434e7ff4ab5b4e62fbb1c931646
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 19, Iss 6, Pp 607-613 (2023)
Chronic heart failure (CHF) is a complex clinical syndrome characterized by poor prognosis. According to the Russian epidemiological study EPOHA-CHF, more than half of patients with CHF have preserved left ventricular ejection fraction (LV EF). Howev
Externí odkaz:
https://doaj.org/article/271daef744344dc3808d5d95a2900133
Publikováno v:
Медицинский вестник Юга России, Vol 12, Iss 2, Pp 6-15 (2021)
Type 2 diabetes mellitus is known to increase the risk of the development of heart failure with preserved ejection fraction and worsen its symptoms. To date, no specific treatment has been shown to reduce morbidity and mortality in patients with hear
Externí odkaz:
https://doaj.org/article/20c614ef720a4118995189e59743e644
Publikováno v:
Терапевтический архив, Vol 92, Iss 3, Pp 125-131 (2020)
Pulmonary hypertension (PH) is a progressive disease which is characterized with the increase of pulmonary artery pressure and pulmonary vascular resistance. Such condition leads to right ventricular heart failure and premature death of patients. Pul
Externí odkaz:
https://doaj.org/article/289b693e941d441cb66b545377d1f9de
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 7 (2021)
The course of hypertension is often complicated by left ventricular hypertrophy (or hypertensive heart disease, HHD). The main “corridor” of natural HHD is development of heart failure with preserved ejection fraction (HFpEF). With HFpEF, the bio
Externí odkaz:
https://doaj.org/article/cff14da5d96c4a3e9b46d1a9c2786f43
Autor:
A. G. Ovchinnikov, A. A. Borisov, K. Yu. Zherebchikova, O. Yu. Ryabtseva, A. D. Gvozdeva, V. P. Masenko, F. T. Ageev, S. A. Boytsov
Publikováno v:
Российский кардиологический журнал, Vol 26, Iss 1 (2021)
Aim. To assess the effect of the sodium-glucose transport protein 2 inhibitor empagliflozin on exercise tolerance and left ventricular (LV) diastolic function in patients with heart failure with preserved ejection fraction (HFpEF) and type 2 diabetes
Externí odkaz:
https://doaj.org/article/941b6979934e4573a7f4a603f0e6cba9
Publikováno v:
Experimental and Clinical Gastroenterology. :97-105
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e544fbed109c47635a4036af39438b4b
https://doi.org/10.31146/1682-8658-ecg-202-6-97-105
https://doi.org/10.31146/1682-8658-ecg-202-6-97-105
Autor:
D. Gvozdeva, A. Myagkova
Publikováno v:
EurasianUnionScientists. :19-21
The article presents the results of a study aimed at studying the peculiarities of social frustration of women before and after self-isolation in connection with the directionality of their personality. The research methods were testing and methods o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8678d6d25f64db490652b3ccfacfae5
https://doi.org/10.31618/esu.2413-9335.2021.5.93.1578
https://doi.org/10.31618/esu.2413-9335.2021.5.93.1578
The Role of Neprilysin Inhibitors in the Treatment of Heart Failure with Preserved Ejection Fraction
Publikováno v:
Kardiologiia. 60:117-127
Clinical and hemodynamic aggravation of heart failure with preserved ejection fraction (HFpEF) is largely due to progression of left ventricular (LV) diastolic dysfunction. The key role in the normal maintenance of diastolic function is played by a h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e4c9cc987b551548a5bf408df10b1101
https://doi.org/10.18087/cardio.2020.11.n1352
https://doi.org/10.18087/cardio.2020.11.n1352
Publikováno v:
Терапевтический архив, Vol 92, Iss 3, Pp 125-131 (2020)
Pulmonary hypertension (PH) is a progressive disease which is characterized with the increase of pulmonary artery pressure and pulmonary vascular resistance. Such condition leads to right ventricular heart failure and premature death of patients. Pul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ffc775e09ee7c881b591c1845720ea78
https://doi.org/10.26442/00403660.2020.03.000591
https://doi.org/10.26442/00403660.2020.03.000591